(Q40080106)

17 September 2017

1 reference

title

Advances in anti-emetic therapy (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

4 August 2023

author name string

M. T. Bakowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6098368

4 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6098368

4 August 2023

publication date

1 September 1984

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0305737284900100?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

https://api.elsevier.com/content/article/PII:0305737284900100?httpAccept=text/plain

4 August 2023

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

4 August 2023

published in

Cancer Treatment Reviews

1 reference

17 September 2017

volume

11

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

237-256

1 reference

Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy

4 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation

4 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

4 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy

4 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy

4 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

4 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways

4 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer Chemotherapy

4 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Metoclopramide as an antiemetic in chemotherapy

4 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Cytostatic-associated vomiting effectively inhibited by domperidone (R 33 812)

4 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy

4 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting

4 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Pharmacokinetics, metabolism and drug-abuse potential of nabilone

4 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients

4 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Suppression of Cancer Chemotherapy-Induced Vomiting in the Cat by Nabilone, a Synthetic Cannabinoid

4 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Controlled Studies of Metopimazine for the Treatment of Nausea and Vomiting

4 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

A CONTROLLED CLINICAL EVALUATION OF ANTIEMETIC DRUGS

4 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Oral benzquinamide in the treatment of nausea and vomiting

4 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics.

4 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Home dialysis does cost less than outpatient dialysis

4 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Behavioral Treatment for the Anticipatory Nausea and Vomiting Induced by Cancer Chemotherapy

4 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Comparative Trial of the Antiemetic Effects of THC and Haloperidol

4 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Pretreatment nausea in cancer chemotherapy: a conditioned response?

4 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis

4 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

4 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis

4 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting

4 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy

4 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Anticipatory Nausea and Vomiting Associated with Cancer Chemotherapy

4 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma

4 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0305-7372(84)90010-0

4 August 2023

Identifiers

1 reference

17 September 2017

1 reference